Hamostaseologie 1985; 05(05/06): 170-173
DOI: 10.1055/s-0038-1655124
Originalarbeiten
Schattauer GmbH

Thrombozyten und Tumorausbreitung

Zur Bedeutung der Blutplättchen und des Plättchenserotonins für die Tumorzellabsiedlung
G Skolnik
1   Abteilungen für Chirurgie I und Anatomie der Universität Göteborg/Schweden
,
H Ahlman
1   Abteilungen für Chirurgie I und Anatomie der Universität Göteborg/Schweden
,
U Bagge
1   Abteilungen für Chirurgie I und Anatomie der Universität Göteborg/Schweden
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

 

 
  • LITERATUR

  • 1 Awouters F, Leysen J. E, De Clerck F, van Nueten J. M. General pharmacological profile of ketanserin (R 41468), a selective 5-HT2 receptor antagonist. In: De Clerck F, Vanhoutte R. M. (Eds.): 5-Hydroxytryptamine in Peripheral Reactions. Raven Press. New York: 1982: 193-198.
  • 2 Bagge U, Skolnik G, Ericson L. E. The arrest of circulating tumor cells in the liver microcirculation. A vital fluorescence microscopic, electron microscopic and isotope study in the rat. J. Cancer Res. Clin. Oncol. 105: 134-140 1983;
  • 3 Bergentz S. E. Studies on the genesis of post-traumatic fat embolism. Acta Chir. Scand. Suppl. 252: 1-72 1961;
  • 4 Boogaerts M. A, Yamada O, Jacob H. S, Moldow C. F. Enhancement of granulocyte-induced cytotoxicity by platelet release products. Proc. Nat. Acad. Sci. (Wash) 79: 7019-7023 1982;
  • 5 Clark R. A, Szot S. The myeloperoxidase-hydrogen peroxide-halide system as effector of neutrophil-mediated tumor cell cytotoxicity. J. Immunol. 126: 1295-1301 1981;
  • 6 Csaba G, Lantos T. Effect of hormones on protozoa. Studies on the phagocytotic effect of histamine, 5-hydroxytryptamine and indolacetic acid in Tetrahymena pyriformis. Cytobiology. 07: 361-365 1973;
  • 7 Dallegri F, Patrone F, Frumento G, Sacchetti C. Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms. J. Natl. Cancer Inst. 73: 331-339 1984;
  • 8 De Clerck F, Reneman R. S. Plateletderived serotonin and abnormal tissue perfusion. In: Serotonin and the Cardiovascular System. Vanhoutte P. M. (Ed.) Raven Press; New York: 1985: 155-164.
  • 9 Dingemans K. P. Morphological aspects of the interaction of blood coagulation and tumor dissemination. In: Hellmann K, Hilgard P, Eccles S. (Eds.): Metastasis. Clinical and Experimental Aspects. Martinus Nijhoff, The Hague; 1980: 85-89.
  • 10 Fidler I. J. Metastasis: quantitative analysis of distribution and fate of tumor emboli labelled with 125I-5-iodo-2-deoxyuridine. J. Natl. Cancer Inst. 45: 773-782 1970;
  • 11 Fisher B, Fisher E. R. Experimental studies of factors influencing hepatic métastasés. III. Effect of surgical trauma with special reference to liver injury. Ann. Surg. 150: 731-744 1959;
  • 12 Gasic G. J, Gasic T. B, Galanti N, Johnson T, Murphy S. Platelet-tumor cell interactions in mice : the role of platelets in the spread of malignant disease. Int. J. Cancer 11: 704-718 1973;
  • 13 Gasic G. J. Role of plasma, platelets and endothelial cells in tumor metastasis. Cancer Metastasis Rev. 03: 99-116 1984;
  • 14 Griffiths J. D. The dissemination of cancer cells during operative procedures. Ann. R. Coll. Surg. Engl. 27: 14-44 1960;
  • 15 Haddy F. J, Scott J. B, Grega G. J. Peripheral circulation: fluid transfer across the microvascular membrane. In: Guyton A. C, Cowley A. W. (Eds.): International Review of Physiology II. vol. 9. University Park Press; Baltimore: 1976: 63-109.
  • 16 Hara Y, Steiner M, Baldini M. G. Platelets as a source of growth-promoting factors for tumor cells. Cancer Res. 40: 1212-1216 1980;
  • 17 Hilgard P. The role of blood platelets in experimental metastases. Brit. J. Cancer 28: 429-435 1973;
  • 18 Hilgard P, Heller H, Schmidt C. G. The influence of platelet aggregation inhibitors on metastasis formation in mice. Z. Krebsforsch 86: 243-250 1976;
  • 19 Honn K. V. Inhibition of tumor cell metastasis by modulation of the vascular prostacyclin/thromboxane A2 system. Clin. Exp. Metast. 01: 103-114 1983;
  • 20 Ivarsson L. Pulmonary metastasis formation after trauma. Acta Chir. Scand. suppl. 463: 1-46 1976;
  • 21 Ivarsson L. Metastasis formation after intravenous tumor cell injection in thrombocytopenic rats. Eur. Surg. Res. 08: 51-60 1976;
  • 22 Jagelman D. G. The vascular dissemination of tumor cells by manipulation of an artificially produced bowel tumor in the rat. Brit. J. Surg. 59: 302 (Abstract) 1972;
  • 23 Jones D. S, Wallace A. C, Fraser E. E. Sequence of events in experimental metastases of Walker 256 tumor. Light, immunofluorescent and electronmicroscopic observations. J. Natl. Cancer Inst. 46: 493-504 1971;
  • 24 Jong E. C, Klebanoff S. J. Eosinophilmediated mammalian tumor cell cytotoxicity, role of the peroxidase system. J. Immunol. 124: 1949-1953 1980;
  • 25 Lewis M. R, Cole W. H. Experimental increase of lung metastases after operative trauma. AMA Arch. Surg. 77: 621-626 1958;
  • 26 Nachman R. L, Weksler B, Ferris B. Characterization of human platelet vascular permeability-enhancing activity. J. Clin. Invest. 51: 549-555 1972;
  • 27 Pearlstein E, Ambrogio C, Karpatkin S. Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT 26 colon adenocarcinoma, Lewis lung carcinoma and B 16 amelanotic melanoma tumor cells into mice. Cancer Res. 44: 3884-3887 1984;
  • 28 Persson B, Hedner T, Henning M. Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent. J. Pharm. Pharmacol. 34: 442-445 1982;
  • 29 Roos E, Dingemans K. P, van de Pavert I. V, van der Berg-Weerman M. A. Mammary carcinoma cells in the mouse liver: infiltration of liver tissue and interaction with Kupffer cells. Brit. J. Cancer. 38: 88-99 1978;
  • 30 Salsbury A. J. The significance of the circulating cancer cell. Cancer Treat. Rev. 02: 55-72 1975;
  • 31 Sindelar W. F, Tralka T. S, Ketcham A. S. Electron microscopic observations on formation of pulmonary metastases. J. Surg. Res. 18: 137-161 1975;
  • 32 Skolnik G, Alpsten M, Ivarsson L. Studies on mechanisms involved in metastasis formation from circulating tumor cells. Factors influencing tumor cell lodgement during normal and post-traumatic conditions. J. Cancer Res. Clin. Oncol. 97: 249-256 1980;
  • 33 Skolnik G, Bagge U, Ericson L. E. Vitaland electron microscopic observations of tumor cell accumulation in the liver. World J. Surg. 05: 442 (Abstract) 1981;
  • 34 Skolnik G, Ericson L. E, Bagge U. The effect of thrombocytopenia and antiserotonin treatment on the lodgement of circulation tumor cells. J. Cancer Res. Clin. Oncol. 105: 30-37 1983;
  • 35 Skolnik G, Bagge U, Dahlström A, Ahlman H. The importance of 5-HT for tumor cell lodgement in the liver. Int. J. Cancer 33: 519-523 1984;
  • 36 Skolnik G, Bagge U, Blomqvist G, Dahlström A, Ahlman H. Involvement of platelet-released 5-HT in tumor cell lodgement. J. Surg. Res. 38: 559-567 1985;
  • 37 Sugarbaker E. V, Ketcham A. S. Mechanisms and prevention of cancer dissemination: an overview. Semin. Oncol. 04: 19-32 1977;
  • 38 Warren B. A, Vales O. The adhesion of thromboplastic tumor emboli to vessel walls in vivo. Brit. J. Exp. Pathol. 53: 301-313 1972;
  • 39 Weksler B, Nachman R. L. Platelets and atherosclerosis. Amer. J. Med. 71: 331-333 1981;
  • 40 Wood Jr. S. Pathogenesis of metastasis formation in vivo in the rabbit ear chamber. AMA Arch. Pathol. 66: 550-569 1958;